Goklas, A., & Thamrin, H. (2023). Effect of Financial Performance on Firm Value in Pharmaceutical Sub-Sector Companies on the IDX. Journal of Economics, Finance and Management Studies, 06(02). DOI: https://doi.org/10.47191/jefms/v6-i2-15 .

Wulandari, A., & Purbawati, D. (2021). The Influence of Intellectual Capital on Firm Value through Financial Performance as an Intervening Variable (Study on Pharmaceutical Sub-Sector Companies Listed on the Indonesia Stock Exchange Periode 2016 - 2019). Jurnal Ilmu Administrasi Bisnis, 10(1), 793–802. DOI: https://doi.org/10.14710/jiab.2021.29801 .

Yana Fajriah, & Edy Jumady. (2022). Good Corporate Governance and Corporate Social Responsibility On Company Value with Financial Performance. Jurnal Akuntansi, 26(2), 324–341. DOI: https://doi.org/10.24912/ja.v26i2.944 .

Firdausi Nuzula, S., & Siregar, C. S. (2022). Analisis Kinerja Keuangan Sektor Farmasi yang Terdaftar di BEI Sebelum dan Saat Covid-19. Fair Value: Jurnal Ilmiah Akuntansi dan Keuangan, 5(2), 941–945. DOI: https://doi.org/10.32670/fairvalue.v5i2.2339 .

Meliani, L. A., & Ariyanto, D. (2021). Kinerja Keuangan Memediasi Pengaruh Modal Intelektual dan Struktur Modal pada Nilai Perusahaan di Masa Pandemi Covid-19. E-Jurnal Akuntansi, 31(10), 2503. DOI: https://doi.org/10.24843/eja.2021.v31.i10.p08 .

Nazir, A., Azam, M., & Khalid, M. U. (2021). Debt Financing and Firm Performance: Empirical Evidence from the Pakistan Stock Exchange. Asian Journal of Accounting Research, 6(3), 324–334. DOI: https://doi.org/10.1108/AJAR-03-2019-0019 .

Siwi, T. P., & Kartika, A. (2022). Analisis Perbandingan Kinerja Keuangan Berdasarkan Psak 23 dan PSAK 72 Mengenai Pendapatan Pada Perusahaan Manufaktur. Fair Value: Jurnal Ilmiah Akuntansi dan Keuangan, 5(4), 1960–1970. DOI: https://doi.org/10.32670/fairvalue.v5i4.2784 .

Nurwulandari, A., Hasanudin, H., & Artardo, B. (2021). Strategy for The Formation of Optimal Capital Structure with Swot Analysis In Pharmaceutical Subsectors Companies. JABE (Journal of Applied Business and Economic), 7(3), 388. DOI: https://doi.org/10.30998/jabe.v7i3.9840 .

Marc, T. F. W., Suciwati, D. P., & Karma, I. G. M. (2022). The Effect of Price Earning Ratio, Firm Size, and Corporate Social Responsibility on Firm Value (Empirical Study on Pharmaceutical Sub-Sector Companies Listed on The Indonesia Stock Exchange 2016 – 2020 Period). Journal of Applied Sciences in Accounting, Finance, and Tax, 5(1), 20–27. DOI: https://doi.org/10.31940/jasafint.v5i1.20-27 .

Lokanan, M. E., & Fernandes, S. A. (2022). The Role of Mergers and Acquisitions In Mitigating The Effects of Corporate Fraud In The Pharmaceutical Sector. Journal of Financial Crime, 29(1), 4–19. DOI: https://doi.org/10.1108/JFC-12-2020-0243 .

Pratiwi, P. W., Kuntari, Y., & Indarti, I. (2022). Analisis Current Ratio, Debt to Equity Ratio, dan Return on Equity pada Perusahaan Farmasi yang Terdaftar di BEI Tahun 2018-2020. Jurnal Ilmiah Aset, 24(1), 49–55. DOI: https://doi.org/10.37470/1.24.1.200 .

Ismail, R. (2023). Analisis Rasio Keuangan Untuk Menilai Kinerja Keuangan Perusahaan Kimia Farma Tbk dan PT Indofarma Tbk Periode waktu 1 Tahun. J-AKSI : Jurnal Akuntansi dan Sistem Informasi, 4(1), 1–7. DOI: https://doi.org/10.31949/jaksi.v4i1.3026 .

Dhany, U. R., Koeshardjono, H., & Agustin, I. (2023). Pengukuran Kinerja Keuangan Menggunakan Alat Ukur Economic Value Added (EVA) dan Market Value Added (MVA). Jurnal Ilmiah Ecobuss, 11(1), 35–41. DOI: https://doi.org/10.51747/ecobuss.v11i1.1339 .

Jaakson, K., Aljaste, H. M., & Uusi-Kakkuri, P. (2019). Dimensions of Organisational Innovativeness And Company Financial Performance In The Biotechnology Sector. International Journal of Manpower, 40(6), 1110–1130. DOI: https://doi.org/10.1108/IJM-02-2018-0078 .

Welly, Y., Zainal, A., Silalahi, M., & Sianipar, M. Y. (2023). The COVID-19 Pandemic Affects Intellectual Capital on the Financial Performance of Pharmaceutical Companies in Indonesia. Ekonomi, Keuangan, Investasi dan Syariah (EKUITAS), 4(3), 919–924. DOI: https://doi.org/10.47065/ekuitas.v4i3.2712 .

Albuhisi, A. M., & Abdallah, A. B. (2018). The Impact of Soft TQM On Financial Performance: The Mediating Roles of Non-Financial Balanced Scorecard Perspectives. International Journal of Quality and Reliability Management, 35(7), 1360–1379. DOI: https://doi.org/10.1108/IJQRM-03-2017-0036 .

Sriwinarti, N. K. (2020). Dialektika Pada Laporan Keuangan: Analisa Kinerja Laporan Keuangan Perusahaan Sektor Farmasi yang Terdaftar Di Bursa Efek Indonesia. Riset, Ekonomi, Akuntansi dan Perpajakan (Rekan), 1(2), 19–28. DOI: https://doi.org/10.30812/rekan.v1i2.929 .

Petronila, T. A., & Surjadi, J. J. (2021). Dampak Moderasi Intensitas Research dan Development terhadap Pengaruh Pengungkapan Corporate Social Responsibility Pada Nilai Perusahaan. Balance: Jurnal Akuntansi, Auditing Dan Keuangan, 17(2), 101–124. DOI: https://doi.org/10.25170/balance.v17i2.2259 .

Chowdhury, L. A. M., Rana, T., & Azim, M. I. (2019). Intellectual capital efficiency and organisational performance: In the context of the pharmaceutical industry in Bangladesh. Journal of Intellectual Capital, 20(6), 784–806. DOI: https://doi.org/10.1108/JIC-10-2018-0171 .

Zwalbong, N. F., Abubakar, H. L., & Ibrahim, U. A. (2022). Financial Reforms in Nigeria and Its Effect on the Performance of Quoted Manufacturing Firms. WSEAS Transactions on Business and Economics, 19, 1443–1451. DOI: https://doi.org/10.37394/23207.2022.19.130 .